7/2016 |
Grant |
|
$3.9M |
|
9/2018 |
Convertible Note |
1 |
$10M |
W.L. Gore &a; Associates
W.L. Gore &a; Associates
W.L. Gore &a; Associates
W.L. Gore &a; Associates
|
3/2020 |
Series D |
|
$0 |
Bain Capital Life Sciences
RA Capital Management
Sanderling Ventures
TPG Capital Asia
Bain Capital Life Sciences
RA Capital Management
Sanderling Ventures
TPG Capital Asia
|
4/2021 |
Series D |
1 |
- |
Asymmetry Ventures
Asymmetry Ventures
|
5/2017 |
Venture Round |
|
$0 |
JDRF (The Juvenile Diabetes Research Foundation)
W.L. Gore &a; Associates
Asset Management Partners
JDRF (The Juvenile Diabetes Research Foundation)
W.L. Gore &a; Associates
Asset Management Partners
|
9/2014 |
Grant |
1 |
$16.6M |
California Institute for Regenerative Medicine
|
12/2017 |
Grant |
1 |
$1.4M |
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine
|
5/2000 |
Series B |
|
- |
|
8/2014 |
Series C |
|
$5.4M |
|
7/2013 |
Series C |
2 |
$10.6M |
Sanderling Ventures
Johnson &a; Johnson Development Corporation
Sanderling Ventures
Johnson &a; Johnson Development Corporation
|
5/2006 |
Venture Round |
|
$0 |
Asset Management Ventures (AMV)
BD Venture
DFJ Portage Ventures
Headland Ventures
Johnson &a; Johnson Development Corporation
Pacific Horizon Ventures
Sanderling Ventures
The Vertical Group
Asset Management Ventures (AMV)
BD Venture
DFJ Portage Ventures
Headland Ventures
Johnson &a; Johnson Development Corporation
Pacific Horizon Ventures
Sanderling Ventures
The Vertical Group
|
11/2018 |
Series D |
|
$0 |
Bain Capital Life Sciences
TPG
RA Capital Management
Sanderling Ventures
Bain Capital Life Sciences
Bain Capital Life Sciences
TPG
RA Capital Management
Sanderling Ventures
Bain Capital Life Sciences
|
7/2007 |
Series C |
|
$0 |
Asset Management Ventures (AMV)
Johnson &a; Johnson Development Corporation
Pacific Horizon Ventures
Sanderling Ventures
Asset Management Ventures (AMV)
Johnson &a; Johnson Development Corporation
Pacific Horizon Ventures
Sanderling Ventures
|
4/2021 |
Series D |
|
$45M |
Adage Capital Partners
Invus Group
Asymmetry Ventures
Artis Ventures
Bain Capital Life Sciences
TPG Capital
RA Capital Management
Sanderling Ventures
|
8/2014 |
Venture Round |
1 |
$20M |
Johnson &a; Johnson Innovation
Johnson &a; Johnson Innovation
|
4/2018 |
Grant |
|
- |
|
4/2018 |
Grant |
1 |
- |
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
|
3/2020 |
Series D |
4 |
$32.6M |
Bain Capital Life Sciences
TPG Capital
RA Capital Management
Sanderling Ventures
Bain Capital Life Sciences
RA Capital Management
Sanderling Ventures
TPG Capital Asia
|
11/2018 |
Series D |
4 |
$80M |
Bain Capital Life Sciences
RA Capital Management
TPG Capital Management
Sanderling Ventures
Bain Capital Life Sciences
TPG
RA Capital Management
Sanderling Ventures
Bain Capital Life Sciences
|
4/2018 |
Grant |
|
- |
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
|
5/2017 |
Equity |
3 |
$10M |
Asset Management Partners
W.L. Gore & Associates, Inc
JDRF
|
4/2021 |
Series D |
1 |
- |
Asymmetry Ventures
Asymmetry Ventures
|
4/2018 |
Grant |
1 |
- |
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
|